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Toward a Better Understanding of...

Induction of IDH2 R140Q Mutation in
Stem Cells with Doxycycline Increases
Rate of Cell Death
Reuben Aaron Hogan
Mentor: David Spencer
Mutations in isocitrate dehydrogenase 1 or 2 (IDH1 or IDH2) occur in a variety of
human cancers. IDH enzymes normally convert isocitrate to alpha-ketoglutarate (αKG)
in the citric acid cycle. However, the cancer-associated mutations occur at specific
positions in each gene, including position 140 of IDH2, and lead to the production of
a novel molecule, R-2-hydroxyglutarate (2HG). 2HG has been shown to result in DNA
and histone hypermethylation of leukemia samples in comparison to normal cells. To
understand how this specifically blocks cellular differentiation and allows increased
proliferation, we set up an experimental model within stem cells.
H9 cells were infected using a lentivirus which delivered DNA containing the
IDH2 R140Q mutation, the GFP gene, and a promoter region that binds a receptor
for doxycycline (DOX). When cells are treated with DOX, the receptors diffuse from
the promoter, allowing transcriptional machinery to take over. The cell then produces
mutant IDH2; however, induction of IDH2 R140Q kills stem cells instead of causing
increased proliferation. Our hypothesis is that there is a differential gene expression in
stem cells from leukemic cells that must be controlled for to use the model.
To test this hypothesis, we generated both an H9 IDH2 R140Q line and a H9 Vector
line. Both were treated with DOX for at least 2 days and were brought up with untreated
samples as controls. GFP expression was measured by flow cytometry as an indicator
of IDH2 R140Q positivity. Cell counts were taken for all conditions (H9 IDH2 and
H9 Vector ± DOX) at different time points to determine the rate of cell death. RNA
sequencing was done for all conditions to determine what genes were differentially
expressed, and analysis was done to compare the expression between samples and with
leukemia tumor samples as well.
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